Filing Details

Accession Number:
0001325812-18-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-08 17:02:09
Reporting Period:
2018-01-04
Accepted Time:
2018-01-08 17:02:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514291 Michael Mason 300 Third Street
Cambridge MA 02142
Vp, Finance And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-04 1,388 $42.22 6,352 No 4 M Direct
Common Stock Acquisiton 2018-01-04 1,667 $63.00 8,019 No 4 M Direct
Common Stock Acquisiton 2018-01-04 3,600 $88.95 11,619 No 4 M Direct
Common Stock Acquisiton 2018-01-04 2,750 $96.45 14,369 No 4 M Direct
Common Stock Acquisiton 2018-01-04 2,750 $96.45 17,119 No 4 M Direct
Common Stock Acquisiton 2018-01-04 10,000 $97.72 27,119 No 4 M Direct
Common Stock Acquisiton 2018-01-04 6,187 $96.45 33,306 No 4 M Direct
Common Stock Acquisiton 2018-01-04 3,439 $63.00 36,745 No 4 M Direct
Common Stock Disposition 2018-01-04 5,249 $130.42 31,496 No 4 S Direct
Common Stock Disposition 2018-01-04 16,500 $131.20 14,996 No 4 S Direct
Common Stock Disposition 2018-01-04 12,405 $132.18 2,591 No 4 S Direct
Common Stock Disposition 2018-01-04 1,591 $132.98 1,000 No 4 S Direct
Common Stock Disposition 2018-01-04 400 $133.83 600 No 4 S Direct
Common Stock Disposition 2018-01-04 600 $135.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Option 2013 (right to buy) Disposition 2018-01-04 1,667 $0.00 1,667 $63.00
Common Stock Performance Stock Option 2014 (right to buy) Disposition 2018-01-04 2,750 $0.00 2,750 $96.45
Common Stock Performance Stock Option 2014 (right to buy) Disposition 2018-01-04 2,750 $0.00 2,750 $96.45
Common Stock Stock Option (right to buy) Disposition 2018-01-04 1,388 $0.00 1,388 $42.22
Common Stock Stock Option (right to buy) Disposition 2018-01-04 3,439 $0.00 3,439 $63.00
Common Stock Stock Option (right to buy) Disposition 2018-01-04 3,600 $0.00 3,600 $88.95
Common Stock Stock Option (right to buy) Disposition 2018-01-04 6,187 $0.00 6,187 $96.45
Common Stock Stock Option (right to buy) Disposition 2018-01-04 10,000 $0.00 10,000 $97.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-09-20 2023-12-17 No 4 M Direct
2,750 2016-02-01 2024-12-17 No 4 M Direct
0 2017-07-07 2024-12-17 No 4 M Direct
4,162 2026-12-20 No 4 M Direct
0 2023-12-18 No 4 M Direct
3,600 2025-12-18 No 4 M Direct
2,063 2024-12-17 No 4 M Direct
0 2015-12-07 2025-12-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 226 Indirect by Managed Account
Footnotes
  1. All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017.
  2. Sale prices ranged from $129.74 to $130.72.
  3. Sale prices ranged from $130.74 to $131.73.
  4. Sale prices ranged from $131.75 to $132.71.
  5. Sale prices ranged from $132.75 to $133.71.
  6. Sale prices ranged from $133.78 to $134.11.
  7. Sale prices ranged from $134.94 to $135.10
  8. The reporting person owns 226 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
  9. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.